Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT03083964 |
Other study ID # |
1512254890 |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
January 18, 2017 |
Est. completion date |
December 11, 2021 |
Study information
Verified date |
November 2023 |
Source |
Indiana University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
The purpose of this study is to A) capture obesogenic cues that occur in daily life, and B)
to deliver cue alerts. Investigators hypothesized that A) black women experience more cues,
B) racial disparities in obesity are reduced in models that adjust for cues, and C) the
priming arm will achieve a weight loss of 2kg or more. Investigators will explore whether
racial disparities in weight loss differ between the groups receiving usual care or those
receiving cues.
Description:
Aim 1: After participants have been consented over the phone or in clinic, the Research
Assistants (RA) will schedule a baseline assessment. Baseline interviewer administered survey
questions, assessments, and equipment set-up will be completed in participants' homes to
allow a physical environment assessment of the home. Assessments and surveys will be carried
out using Research Electronic Data Capture (REDCap; see Resources). The in-home baseline
assessment piloted for the proposed study takes 1 to 1.5 hours. Global Positioning System
(GPS) locating, accelerometry, bite monitoring, and EMA surveys will operate through the
mHealth app over the immediate 2-4 week period. For GPS locating, the mHealth app uses
software that identifies and sends the longitude and latitude at the time of EMA response to
a secure IU server. Software then determines the address of the location and whether it is
the participant's home, work, restaurant, retail store, etc. For messaging, the mHealth app
uses "Push Notification" to deliver EMA requests to the device (i.e., smartphone). This
bypasses the phone carrier's Short Message Service (SMS) gateway, which is not always
reliable or secure. The mHealth app makes sure the messages are delivered and secure.
Participants receive a notification and open the application to answer the EMA questions. The
database is located in a secure network within Indiana University servers. None of the data
are stored inside the smartphone at rest. The actual questions are very brief with radio
button responses.
At the end of the 2-4 week window, RAs will return to the home to collect the accelerometer
and bite counter which takes about 1 hour. The accelerometer and bite counter are to be
marked by the RA with the study participants ID and data are retrieved. At this time,
participants who responded to 75% or more of the messages over the 2-4 week period, will be
randomized to Usual Care (UC) or Priming Arm for Aim 2 and given instruction on the next
steps of study participation. Randomization will be carried out within each race group to
ensure a balance in the number of subjects between the two treatment arms. The Investigator
will computer-generate randomization lists in field envelopes to be provided to the RAs for
treatment assignment.
Aim 2: The second aim of the study will last 6 months. Both UC and Priming arms will have
full access to Healthy-Me coaches and classes as well as receive training and access to the
mHealth app. When study participation is excluded, all apps and associated data will be
removed from the smartphone. At no time will Patient Health Information (PHI) be stored on
the smartphone. Smartphones will only be identified by study ID number and the developer will
only have access to the participants' study ID number and smartphone data collected by the
mHealth app. Subjects in UC and Priming will undergo similar assessments and procedures;
however, the Priming arm participants will, in addition receive 6-8 message alerts per day.
The application and notifications that will be used in the Priming arm will be built from
each participants own library to be delivered at times and in locations that their Aim 1 data
indicate they often experience an eating or sedentary cue. In short, this intervention
counters an obesogenic cue with a "healthy" prime in real-time and location.
Finally, following 6 months of UC or Priming, blinded RAs will return to participants home to
complete 6-month follow-up assessment and collect all study related equipment. The final
assessment and surveys will take about 1-1.5 hours and all data captured will also be carried
out in REDCap.